Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists. (Q45280327)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15727952%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15727952%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15727952%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Theodore P Ciaraldi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15727952%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Kyong-Soo Park

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15727952%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Leslie Carter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15727952%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sunder R Mudaliar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15727952%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Robert R Henry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15727952%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

22 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15727952%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Endocrinology and Metabolism

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15727952%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

289

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15727952%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15727952%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

E151-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15727952%20AND%20SRC:MED&resulttype=core&format=json

Ceramide content is increased in skeletal muscle from obese insulin-resistant humans

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

The fate of [U-(13)C]palmitate extracted by skeletal muscle in subjects with type 2 diabetes and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Mechanisms of fatty acid-induced inhibition of glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Regulation of fatty acid transport and membrane transporters in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Substrate utilization in non-obese Type II diabetic patients at rest and during exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Troglitazone action is independent of adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Mechanism of cellular uptake of long-chain fatty acids: Do we need cellular proteins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

The role of intramuscular lipid in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Insulin resistance: From predisposing factor to therapeutic target in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Muscle-specific Pparg deletion causes insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Skeletal muscle lipid metabolism with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Muscle triglyceride and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Estimation of peroxisomal and mitochondrial fatty acid oxidation in rat hepatocytes using tritiated substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004

Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00141.2004